|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7811254||MERIDIAN MEDCL||Autoinjector with needle depth adapter||
(4 years from now)
Treatment: Acute treatment of migraine attacks, with or without aura, and the treatment of cluster headache episodes
|EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)||INJECTABLE;SUBCUTANEOUS||Discontinued|
Click on the highlighted region to filter.